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ABSTRACT
Background Marie Unna hereditary hypotrichosis
(MUHH) is an autosomal dominant disorder
characterised by coarse, wiry, twisted hair developed in
early childhood and subsequent progressive hair loss.
MUHH is a genetically heterogeneous disorder. No gene
in 1p21.1–1q21.3 region responsible for MUHH has been
identified.
Methods Exome sequencing was performed on two
affected subjects, who had normal vertex hair and
modest alopecia, and one unaffected individual from a
four-generation MUHH family of which our previous
linkage study mapped the MUHH locus on chromosome
1p21.1–1q21.3.
Results We identified a missense mutation in EPS8L3
(NM_024526.3: exon2: c.22G->A:p.Ala8Thr) within
1p21.1–1q21.3. Sanger sequencing confirmed the
cosegregation of this mutation with the disease
phenotype in the family by demonstrating the presence
of the heterozygous mutation in all the eight affected and
absence in all the seven unaffected individuals. This
mutation was found to be absent in 676 unrelated
healthy controls and 781 patients of other disease from
another unpublished project of our group.
Conclusions Taken together, our results suggest that
EPS8L3 is a causative gene for MUHH, which was
helpful for advancing us on understanding of the
pathogenesis of MUHH. Our study also has further
demonstrated the effectiveness of combining exome
sequencing with linkage information for identifying
Mendelian disease genes.
INTRODUCTION
Hereditary hypotrichosis is a kind of inherited hair
disorder which can grossly be characterised into
two major groups according to the absence (non-
syndromic hereditary hypotrichosis) or presence
(syndromic hereditary hypotrichosis) of extra-
cutaneous features. Alopecia universalis congenita/
alopecia alopecia congenita with papular lesions
(AUC/APL), hereditary hyportrichosis simplex
(HHS), localised autosomal recessive hypotrichosis
and Marie Unna hereditary hypotrichosis (MUHH;
OMIM 146550/612841) are different forms of non-
syndromic hereditary hypotrichosis. AUC/APL is
characterised by early-onset, complete hair loss
including eyebrows, eyelashes, armpit hair, pubic
hair and body hair, and/or small erythematous
papules of head and neck. Individuals with HHS
typically show normal hair at birth, but hair loss
and thinning of the hair shaft start without charac-
teristic hair shaft anomalies during early childhood
and progress with age. The affected individuals of
HHS are affected scalp hair and/or body hair. The
individuals with localised autosomal recessive
hypotrichosis have hypotrichosis simplex with
shortened length of the hair shaft, skin fragility/
ectodermal dysplasia and woolly hair with palmo-
plantar keratoderma and cardiomyopathy syn-
drome, and associated with absence or scarcity of
eyebrows, eyelashes and pubic hair.
MUHH is a rare autosomal dominant congenital
hair disorder which was first described by the
German dermatologist Marie Unna.1 MUHH is dis-
tinguished from other forms of hypotrichosis by
the presence of a twisting hair; affected individuals
of this disease have normal, sparse or absent hair at
birth, then develop to coarse, twisted and wiry hair
during childhood and progress during puberty to an
almost complete alopecia. Eyebrows, eyelashes and
body hair are also markedly diminished or absent.
No other ectodermal abnormalities are observed. So
far, two linkage loci for MUHH have been mapped
to chromosome 8p212 and 1p21.1–1q21.3.3 After
that, an international collaboration discovered that
MUHH is caused by heterozygous mutations in
the second 50-untranslated region of the HR gene
(U2HR) recently.4 The MUHH pedigree in this
study was reported previously by Yan et al5 and
Yang et al.3 The former study found that affected
individuals had little or no scalp hair at birth, wiry
and irregular hair on the scalp that had been diffi-
cult to manage in childhood, and their forehead
and parietal hair were bald or sparse in puberty.
Eyebrows and eyelashes had always been thin.
Axillary and pubic hair failed to develop. But the
affected individuals have modest scarring alopecia
and normal vertex hair. The sequent study had
identified a locus for MUHH on chromosome
1p21.1–1q21.3 in this family.
For the past decades, the genes underlying
Mendelian diseases have been identified through
positional cloning, a process of meiotic mapping,
physical mapping and candidate-gene sequencing.
Recently, exome sequencing (also known as tar-
geted exome capture) was demonstrated to be a
cheaper but efficient strategy to selectively
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sequence the whole genome coding regions. It has been widely
used to identify genes for rare monogenic diseases and can also
provide molecular identification of Mendelian diseases when
the clinical diagnosis is uncertain.6–9 Here, we identified a novel
causative gene for MUHH by combining exome sequencing
with the linkage information from our previous study.3
MATERIALS AND METHODS
Clinical sample
A four-generation MUHH family consisting of 21 individuals
was first reported by Yan et al5 from Anhui province in China
(figure 1A). There were nine affected individuals including four
males and five female subjects. After obtaining written
informed consent from all the participants, EDTA anticoagu-
lated venous blood samples were collected from eight patients
and seven controls. The clinical features, histological character-
istics, light microscopic examination and disease history sup-
ported the diagnosis of MUHH.5 Sanger sequencing was
performed to exclude U2HR mutation in this family. After
that, two affected individuals (II3 and III10) and one
unaffected individual (III2) were selected for exome sequencing.
An additional 12 members (six cases and six controls) were
evaluated in mutation validation analyses.
In addition, the unpublished exome sequencing data of eth-
nically and geographically matched 1457 subjects including 676
unrelated controls and 781 unrelated patients of other disease
were used to filter variants. All the 1457 subjects were excluded
MUHH by at least two dermatologist examinations.
Genomic DNA was extracted from peripheral blood lympho-
cytes by standard procedures using FlexiGene DNA kits
(Qiagen, California, USA). This study was approved by Anhui
Medical Institutional Review Board and conducted according to
the Declaration of Helsinki Principles.
Exome capture library preparation and capture
Exome capture was carried out using Agilent SureSelect
Human All Exon Kit (in solution), guided by the manufac-
turer ’s protocols. In brief, the qualified genomic DNA samples
were randomly fragmented to 200–500 bp in size, followed by
end-repair, A-tailing and paired-end index adapter ligation.
Ligation-mediated PCR amplified extracted DNA purified by
the Agencourt AMPure SPRI beads. Final libraries were vali-
dated by Bioanalyzer analysis (Agilent) and quantitative PCR.
Each captured library was loaded on Hiseq 2000 platform and
paired-end sequencing was performed, with read lengths of
90 bp, providing at least 50 average depth for each sample. Raw
image files were processed by Illumina pipeline (V.1.3.4) for
base calling with default parameters.
Next-generation sequencing data analysis
SOAPaligner 2.2010 11 was used to align the reads to human ref-
erence hg19 with parameters set to ‘-a -b -D -o -v 2 -r 1 -t -n 4’.
SOAPsnp (V.1.03)12 was used to call consensus genotypes with
Phred-like quality of at least 20 and at least four coverage depth
was considered as the high-confident genotype. SNP (single
nucleotide polymorphisms) were extracted from consensus
Figure 1 (A) The genealogical tree.
‘+’ in pedigree indicates those who
are subjected to exome sequencing,
and ‘−’ in pedigree indicates those
who had undergone Sanger
sequencing. (B) Chromatogram of the
heterozygous c.22G>A variant
resulting in the EPS8L3 Ala8Thr
substitution. This figure is only
reproduced in colour in the online
version.
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genotypes files, and those achieved minimum quality score:
Phred-like quality≥20, overall depth from 4 to 200, copy
number estimate <2 and distance between two adjacent SNPs
no less than 5.
For indels calling, BWA (V.0.5.8)13 was used to gap align the
sequence reads with default parameters to the human reference
hg19. GATK IndelRealigner14 was used to perform local realign-
ment of the BWA-aligned reads and GATK IndelGentotyperV2
was used to call indels.
The variants were functionally annotated using an inhouse
pipeline and categorised into missense, nonsense, read-through,
splice-site mutations and coding indels, which are likely to be
deleterious compared with synonymous and non-coding muta-
tions. Based on these annotations, variants were filtered first
for the non-synonymous (NS), splice acceptor and donor site
(SS) mutations and coding indels (I), and then filtered against
the most updated dbSNP database (V.135) and the control step
by step. At last, the variants were shared between two cases
but were neither presented in the public databases nor in the
control individual of the family were considered to be the can-
didate variants.
To equally assess the functional importance of NS/SS/I
mutations, the disease-causing variants were predicted by
ANNOVAR15 16 and PhastCons conservative score17 analysis.
Sanger sequencing
Validation of the mutation was performed by Sanger sequencing
in all the members of this family whose DNAs were available.
PCR amplification was carried out in ABI 9700 Thermal Cycler
using standard conditions. After the amplification, products
were purified using a QIAquick PCR Purification Kit (Qiagen)
and directly sequenced on ABI PRISM 3730 automated sequen-
cer (Applied Biosystems). Sequence comparisons and analysis
were performed by Phred-Phrap-Consed program, V.12.0.
RESULTS
We conducted exome sequencing in two affected individuals (II3
and III10) and one unaffected individual (III2) from one Chinese
MUHH family where locus was mapped to 1p21.1–1q21.3.3
A 5.85 Gb of average sequence was generated per individual as
paired-end, 90-bp reads. After discarding the reads that had
duplicated start sites and then mapping to the human reference
genome (NCBI Build 37, hg19), 2.44 Gb mapped, targeted
exome sequences with a mean depth of 64.83-fold were
achieved. On average, 88.41% of the exome was covered at
least 10-fold.
As mentioned in previous studies, we focused our analyses
primarily on NS variants, SS and coding insertions/deletions
(indels) that are more likely to be pathogenic mutations8 18
(table 1). In addition, we predicted that variants underlying
MUHH are rare and thus unlikely to be identified previously.
We therefore selected the variants that were absent from the
most updated dbSNP database (V.135) for further analysis.
Assuming a dominant model, we found 91 novel NS/SS/indels
that were shared by the two affected individuals but absent in
the unaffected individual in this family. Of the 91 variants,
only one heterozygous mutation in EPS8L3 (NM_024526.3:
exon2: c.22G->A:p.Ala8Thr) was found to be located within
the linkage region on 1p21.1–1q21.3 established in our previous
linkage study.3 The mutation was predicted to be ‘damaging’
with 99.7% confidence by ANNOVAR program15 16 and affect
a conserved amino-acid residue by PhastCons software
(PhastCons score great than 0.99),17 respectively. Therefore, we
selected EPS8L3 as MUHH causative gene for further study.
We then analysed the mutation in all the available affected
and unaffected individuals (including three samples performed
with exome sequencing) of this family by Sanger sequencing.
All the eight affected individuals carried this heterozygous
mutation in EPS8L3 (NM_024526.3: exon2: c.22G->A:p.
Ala8Thr) which was absent in the seven unaffected family
members, suggesting complete cosegregation between the
mutation and MUHH phenotype (figure 1B). Furthermore, this
mutation was not detected in additional exome sequencing
data of 676 unrelated, ethnically and geographically matched
controls, as well as within the exome sequencing data of 781
unrelated, ethnically and geographically matched patients of
other disease. All these results suggested that this mutation is a
causal variant for MUHH, instead of a rare polymorphism.
DISCUSSION
In this study, we identified a missense mutation in EPS8L3
(NM_024526.3: exon2: c.22G->A:p.Ala8Thr) which located
within the linkage region 1p21.1–1q21.3 in this family.3 This
mutation was predicted to be damaging by the ANNOVAR
program15 16 and affect a conserved amino-acid residue by
PhastCons software.17 Subsequently, we confirmed that the
mutation showed a complete cosegregation with the disease
phenotype in the family, carried by all the eight affected and
absent in all the seven unaffected individuals. We further con-
firmed the absence of the mutation in additional 676 controls
and 781 subjects of other disease. Taken together, our findings
have strongly implicated EPS8L3 as a new gene for MUHH.
In mammals, the EPS8 gene family contains EPS8, EPS8L1,
EPS8L2 and EPS8L3. These four proteins share collinear top-
ology and contain a putative PTB (phosphotyrosine binding)
domain, an SH3 domain and a C-terminal effector region. EPS8
is involved in the well-established pathway of epidermal
growth factor receptor (EGFR), which is known to transmit
extra-cellular mitogenic signals, such as EGF and transforming
growth factor-α through activating a number of downstream
signalling cascades like Rac and Rab5.19 EGFR signalling is
indispensable for the initiation of hair growth because the
outer root sheath EGFR expression is downregulated with the
completion of follicular growth.20 Epithelial EGFR expression is
important in delaying follicular differentiation that may serve
to protect the hair follicle from immunological reactions.21
Interesting, EGFR was found to control hair cycle progression
and is crucial for hair follicle morphogenesis and development
Table 1 Summary of detected variants across three exomes
Variants II3 III10 III2
Total number of variants (SNP+coding
indels)
49 574+233 52 420+260 56 353+393
Synonymous-coding 8148 8369 8345
Missense 7139 7223 7148
Nonsense 57 67 59
Read-through 8 5 5
Splice site* 358 354 379
Intron 31 047 33 355 36 874
50 UTRs† 745 826 975
30 UTRs† 1507 1650 1865
Intergenic 565 571 703
Frameshift indels 120 131 227
Inframe indels 113 129 166
*Intronic SNPs within 4 bp of exon/intron boundary.
†Mutations in untranslated regions (UTRs) with 200 bp 50 of initiation codon or 30 of
termination codon.
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in mouse.20 In addition, defective and excessive transforming
growth factor-α/EGFR signalling leads to abnormal hair mor-
phogenesis and hairless phenotype, respectively.22–24 Taken
together, these data suggested that EPS8L3 mutation might
cause MUHH by resulting in hair follicle reduction through
EGFR signalling pathway. Besides that, EPS8 was found to be
unregulated according to all bulge expression profile, suggesting
EPS8 might be a bulge molecular signature gene expressed in
hairspheres. As the bulge region of the hair follicle serves as a
repository for epithelial stem cells that can regenerate the fol-
licle in each hair growth cycle and contribute to epidermis
regeneration upon injury, this might suggest that EPS8 plays a
role in maintaining stem cells.25 26 Of course, further study is
warranted to determine whether this relationship between
EPS8 family and stem cells could contribute to MUHH or not.
In conclusion, our study identified EPS8L3 as a disease gene
for MUHH by combining exome sequencing with previously
established linkage information in a large multi-generation
MUHH family of Chinese population. Further biological studies
of EPS8L3 would shed new insights into the genetic aetiology
and pathophysiology of MUHH. Our study has also demon-
strated the effectiveness of exome sequencing, combined with
linkage analysis, in discovering disease genes for Mendelian
disorders.
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